e-learning
resources
Berlin 2008
Monday, 06.10.2008
Cystic fibrosis: new mechanisms, monitoring and treatment tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased arterial stiffness in adult patients with cystic fibrosis
J. H. Hull, R. Garrod, T. Ho, R. Knight, J. R. Cockcroft, D. J. Shale, C. E. Bolton (London, Surrey, Cardiff, United Kingdom)
Source:
Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Session:
Cystic fibrosis: new mechanisms, monitoring and treatment tools
Session type:
E-Communication Session
Number:
2858
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. H. Hull, R. Garrod, T. Ho, R. Knight, J. R. Cockcroft, D. J. Shale, C. E. Bolton (London, Surrey, Cardiff, United Kingdom). Increased arterial stiffness in adult patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 2858
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Increased arterial stiffness in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 1536-1537
Year: 2012
Increased augmentation index in patients with cystic fibrosis
Source: Eur Respir J 2009; 34: 1322-1328
Year: 2009
Pulmonary hypertension in cystic fibrosis patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 387s
Year: 2007
Exercise capacity and pulmonary artery pressure in adults with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Microcirculation alterations in adult patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006
Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis
Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance
Year: 2012
Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021
Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Relationship between respiratory muscle strength and pulmonary function in children with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 730s
Year: 2006
Electrocardiographical characteristics of pulmonary arterial hypertension in children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Glycaemic variability indices are associated with increased pulmonary function decline in people with cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring
Year: 2018
Relationship between pulmonary functions and respiratory muscle strength in children with non cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 698s
Year: 2004
Skeletal muscle metabolism in active cystic fibrosis (CF) patients with light/moderate pulmonary dysfunction
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept